Chondrocytes from osteoarthritic cartilage of obese patients show altered adiponectin receptors expression and response to adiponectin.


Journal

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
ISSN: 1554-527X
Titre abrégé: J Orthop Res
Pays: United States
ID NLM: 8404726

Informations de publication

Date de publication:
Nov 2021
Historique:
revised: 27 11 2020
received: 02 09 2020
accepted: 19 01 2021
pubmed: 24 1 2021
medline: 19 4 2022
entrez: 23 1 2021
Statut: ppublish

Résumé

Obesity and osteoarthritis (OA) are well-known comorbidities and their precise molecular interactions are still unidentified. Adiponectin, a major adipokine, known to have an anti-inflammatory effect in atherosclerosis or Type 2 Diabetes Mellitus (T2DM), has also been postulated to be pro-inflammatory in OA. This dual role of adiponectin is still not explained. The precise mechanism by which adiponectin affects cartilage and chondrocytes remains to be elucidated. In the present observational study chondrocytes from 30 patients with OA (18 females and 12 males) undergoing total knee replacement (TKR) were isolated. Expression of adiponectin receptors 1 and 2 (ADIPOR1 and ADIPOR2) was examined both at gene and protein levels in chondrocytes. The difference in adiponectin receptor expression between lean and obese patients with OA and the role of adiponectin in regulating pro-inflammatory genes (MCP-1, IL-6, and VCAM-1, MMP-1, MMP-2, and TIMP-1) has been investigated. We found that ADIPOR1 represented the most abundant adiponectin receptor in primary OA chondrocytes. ADIPOR1 and ADIPOR2 genes and ADIPOR1 protein were differently expressed in OA chondrocytes obtained from obese compared with lean patients with OA. Adiponectin induced gene expression of MCP-1, IL-6, and MMP-1 in all OA patients' chondrocytes. In contrast, VCAM-1 and MMP-2 were differently regulated by adiponectin depending on the patient's body mass index. This study suggests that adiponectin and ADIPOR1 may have important roles in the pathogenesis of cartilage degeneration in OA of obese subjects.

Identifiants

pubmed: 33484170
doi: 10.1002/jor.24993
doi:

Substances chimiques

Adiponectin 0
Interleukin-6 0
Receptors, Adiponectin 0
Vascular Cell Adhesion Molecule-1 0
Matrix Metalloproteinase 2 EC 3.4.24.24
Matrix Metalloproteinase 1 EC 3.4.24.7

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2333-2339

Informations de copyright

© 2021 Orthopaedic Research Society. Published by Wiley Periodicals LLC.

Références

Silverwood V, Blagojevic-Bucknall M, Jinks C, Jordan JL, Protheroe J, Jordan KP. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthr Cartil. 2015;23:507-515.
Marks R. Obesity profiles with knee osteoarthritis: correlation with pain, disability, disease progression. Obesity. 2007;15:1867-1874.
Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, hip and/or hand: an epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord. 2008;9:132.
van Andel M, Heijboer AC, Drent ML. Adiponectin and its isoforms in pathophysiology. Adv Clin Chem. 2018;85:115-147.
Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995;270:26746-26749.
Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Med. 2007;13:332-339.
Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes. 2008;32:S13-S18.
Francin PJ, Abot A, Guillaume C, et al. Association between adiponectin and cartilage degradation in human osteoarthritis. Osteoarthr Cartil. 2014;22:519-526.
Harasymowicz NS, Clement ND, Azfer A, Burnett R, Salter DM, Simpson A. Regional differences between perisynovial and infrapatellar adipose tissue depots and their response to class II and class III obesity in patients with osteoarthritis. Arthritis Rheumatol. 2017;69:1396-1406.
Gegout PP, Francin PJ, Mainard D, Presle N. Adipokines in osteoarthritis: friends or foes of cartilage homeostasis? Joint, Bone, Spine. 2008;75:669-671.
de Boer TN, van Spil WE, Huisman AM, et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthr Cartil. 2012;20:846-853.
Hao D, Li M, Wu Z, Duan Y, Li D, Qiu G. Synovial fluid level of adiponectin correlated with levels of aggrecan degradation markers in osteoarthritis. Rheumatol Int. 2011;31:1433-1437.
Orellana C, Calvet J, Berenguer-Llergo A, et al. Synovial adiponectin was more associated with clinical severity than synovial leptin in women with knee. Osteoarthr Cartil. 2020:1947603520904776.
Griffin TM, Fermor B, Huebner JL, et al. Diet-induced obesity differentially regulates behavioral, biomechanical, and molecular risk factors for osteoarthritis in mice. Arthritis Res Ther. 2010;12:R130.
Louer CR, Furman BD, Huebner JL, Kraus VB, Olson SA, Guilak F. Diet-induced obesity significantly increases the severity of posttraumatic arthritis in mice. Arthritis Rheum. 2012;64:3220-3230.
Lago R, Gomez R, Otero M, et al. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthr Cartil. 2008;16:1101-1109.
Chen TH, Chen L, Hsieh MS, Chang CP, Chou DT, Tsai SH. Evidence for a protective role for adiponectin in osteoarthritis. Biochim Biophys Acta-Mol Basis Dis. 2006;1762:711-718.
Wang Q, Cai J, Wang J, et al. Down-regulation of adiponectin receptors in osteoarthritic chondrocytes. Cell Biochem Biophys. 2014;70:491-497.
Francin PJ, Guillaume C, Humbert AC, et al. Association between the chondrocyte phenotype and the expression of adipokines and their receptors: evidence for a role of leptin but not adiponectin in the expression of cartilage-specific markers. J Cell Physiol. 2011;226:2790-2797.
Kang EH, Lee YJ, Kim TK, et al. Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res Ther. 2010;12:R231.
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439-451.
Honsawek S, Chayanupatkul M. Correlation of plasma and synovial fluid adiponectin with knee osteoarthritis severity. Arch Med Res. 2010;41:593-598.
Conde J, Scotece M, López V, et al. Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One. 2012;7:e52533.
Kalichman L, Pantsulaia I, Kobyliansky E. Association between vascular cell adhesion molecule 1 and radiographic hand osteoarthritis. Clin Exp Rheumatol. 2011;29:544-546.
Tong KM, Chen CP, Huang KC, et al. Adiponectin increases MMP-3 expression in human chondrocytes through AdipoR1 signaling pathway. J Cell Biochem. 2011;112:1431-1440.
Lipari L, Gerbino A. Expression of gelatinases (MMP-2, MMP-9) in human articular cartilage. Int J Immunopathol Pharmacol. 2013;26:817-823.
Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007;38:151-156.

Auteurs

Natalia Sara Harasymowicz (NS)

Department of Orthopaedics and Trauma, The University of Edinburgh, Edinburgh, UK.

Asim Azfer (A)

Bone Research Group, Center for Genomics and Experimental Medicine, The University of Edinburgh, Edinburgh, UK.

Richard Burnett (R)

Department of Orthopaedics and Trauma, Royal Infirmary of Edinburgh, Edinburgh, Edinburgh, UK.

Hamish Simpson (H)

Department of Orthopaedics and Trauma, The University of Edinburgh, Edinburgh, UK.

Donald M Salter (DM)

Bone Research Group, Center for Genomics and Experimental Medicine, The University of Edinburgh, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH